Causes-of-death analysis of patients with cardiac resynchronization therapy: An analysis of the CeRtiTuDe cohort study

European Heart Journal

Volumn 36, Issue 41, 2015, Pages 2767-2776

  Marijon, Eloi ^a,b,c   Leclercq, Christophe ^d   Narayanan, Kumar ^c   Boveda, Serge ^e   Klug, Didier ^f   Lacaze Gadonneix, Jonathan ^a,b   Defaye, Pascal ^g   Jacob, Sophie ^h   Piot, Olivier ⁱ   Deharo, Jean Claude ^j   Perier, Marie Cecile ^c   Mulak, Genevieve ^k   Hermida, Jean Sylvain ^l   Milliez, Paul ^m   Gras, Daniel ⁿ   Cesari, Olivier ^o   Hidden Lucet, Francoise ^p   Anselme, Frederic ^q   Chevalier, Philippe ^r   Maury, Philippe ^s   Sadoul, Nicolas ^t   Bordachar, Pierre ^u   Cazeau, Serge ^v   Chauvin, Michel ^w   Empana, Jean Philippe ^c   Jouven, Xavier ^a,b,c   Daubert, Jean Claude ^d   Le Heuzey, Jean Yves ^a,b,c   more..

^a HÔPITAL EUROPÉEN GEORGES POMPIDOU   (France)

^b UNIVERSITÉ PARIS DESCARTES   (France)

^c PARIS CARDIOVASCULAR RESEARCH CENTER   (France)

^d PONTCHAILLOU UNIVERSITY HOSPITAL   (France)

^e CLINIQUE PASTEUR   (France)

^f LILLE UNIVERSITY HOSPITAL   (France)

^g GRENOBLE UNIVERSITY HOSPITAL   (France)

^h INSTITUT DE RADIOPROTECTION ET DE SÛRETÉ NUCLÉAIRE IRSN   (France)

ⁱ CENTRE CARDIOLOGIQUE DU NORD   (France)

^j TIMONE HOSPITAL   (France)

^k French Society of Cardiology   (France)

^l AMIENS UNIVERSITY HOSPITAL   (France)

^m CAEN UNIVERSITY HOSPITAL   (France)

ⁿ Department of Cardiology   (France)

^o Clinique Saint Gatien   (France)

^p PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^q ROUEN UNIVERSITY HOSPITAL   (France)

^r LOUIS PRADEL HOSPITAL   (France)

^s CHU RANGUEIL   (France)

^t UNIVERSITY HOSPITAL OF NANCY   (France)

^u HAUT LÉVÊQUE HOSPITAL   (France)

^v SAINT JOSEPH HOSPITAL   (France)

^w UNIVERSITY HOSPITAL OF STRASBOURG   (France)

more..

Author keywords

Cardiac resynchronization; Cardioverter defibrillator; Competing risk; Heart failure; Sudden death

Indexed keywords

AGED; ARTICLE; ATRIAL FIBRILLATION; CARDIAC RESYNCHRONIZATION THERAPY; CARDIOVASCULAR MORTALITY; CAUSE OF DEATH; COHORT ANALYSIS; COMORBIDITY; COMPARATIVE STUDY; CORONARY ARTERY DISEASE; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY RATE; MULTICENTER STUDY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; PROSPECTIVE STUDY; RISK FACTOR; SEX DIFFERENCE; CARDIAC RESYNCHRONIZATION THERAPY DEVICE; CLINICAL TRIAL; DEATH, SUDDEN, CARDIAC; EVALUATION STUDY; HEART FAILURE; IMPLANTABLE CARDIOVERTER DEFIBRILLATOR; MIDDLE AGED; MORTALITY; PROGNOSIS;

AGED; CARDIAC RESYNCHRONIZATION THERAPY; CARDIAC RESYNCHRONIZATION THERAPY DEVICES; DEATH, SUDDEN, CARDIAC; DEFIBRILLATORS, IMPLANTABLE; EPIDEMIOLOGIC METHODS; FEMALE; HEART FAILURE; HUMANS; MALE; MIDDLE AGED; PROGNOSIS;

EID: 84983151012     PISSN: 0195668X     EISSN: 15229645     Source Type: Journal    
DOI: 10.1093/eurheartj/ehv455     Document Type: Article

References (40)

1. Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF). Lancet 1999; 353:2001-2007.
2. Bardy GH, Lee KL, Mark DB, Poole JE, Packer DL, Boineau R, Domanski M, Troutman C, Anderson J, Johnson G, McNulty SE, Clapp-Channing N, Davidson-Ray LD, Fraulo ES, Fishbein DP, Luceri RM, Ip JH, Sudden Cardiac Death in Heart Failure Trial I. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med 2005;352:225-237.
3. Cleland JG, Daubert JC, Erdmann E, Freemantle N, Gras D, Kappenberger L, Tavazzi L, Cardiac Resynchronization-Heart Failure Study Investigators. The effect of cardiac resynchronization on morbidity and mortality in heart failure. N Engl J Med 2005;352:1539-1549.
4. Linde C, Leclercq C, Rex S, Garrigue S, Lavergne T, Cazeau S, McKenna W, Fitzgerald M, Deharo JC, Alonso C, Walker S, Braunschweig F, Bailleul C, Daubert JC. Long-term benefits of biventricular pacing in congestive heart failure: results from the MUltisite STimulation in cardiomyopathy (MUSTIC) study. J Am Coll Cardiol 2002;40:111-118.
5. Gold MR, Linde C, Abraham WT, Gardiwal A, Daubert JC. The impact of cardiac resynchronization therapy on the incidence of ventricular arrhythmias in mild heart failure. Heart Rhythm 2011;8:679-684.
6. Bristow MR, Saxon LA, Boehmer J, Krueger S, Kass DA, De Marco T, Carson P, DiCarlo L, DeMets D, White BG, DeVries DW, Feldman AM, Comparison of Medical Therapy Pacing and Defibrillation in Heart Failure Investigators. Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure. N Engl J Med 2004;350:2140-2150.
7. Moss AJ, Hall WJ, Cannom DS, Klein H, Brown MW, Daubert JP, Estes NA III, Foster E, Greenberg H, Higgins SL, Pfeffer MA, Solomon SD, Wilber D, Zareba W, MADIT-CRT Trial Investigators. Cardiac-resynchronization therapy for the prevention of heart-failure events. N Engl J Med 2009;361:1329-1338.
8. Daubert JC, Donal E, Linde C. A plea for the wider use of CRT-P in candidates for cardiac resynchronisation therapy. Heart Fail Rev 2012;17:767-775.
9. Linde C, Gold MR, Abraham WT, St John Sutton M, Ghio S, Cerkvenik J, Daubert C, REsynchronization reVErses Remodeling in Systolic left vEntricular dysfunction Study Group. Long-term impact of cardiac resynchronization therapy in mild heart failure: 5-year results from the REsynchronization reVErses Remodeling in Systolic left vEntricular dysfunction (REVERSE) study. Eur Heart J 2013;34:2592-2599.
10. Aktas MK, Huang DT, Daubert JP, Schuger CD, McNitt S, Goldenberg I, Moss AJ, Zareba W. Effect of defibrillation threshold testing on heart failure hospitalization or death in the Multicenter Automatic Defibrillator Implantation Trial-Cardiac Resynchronization Therapy (MADIT-CRT). Heart Rhythm 2013;10:193-199.
11. Singh JP, Klein HU, Huang DT, Reek S, Kuniss M, Quesada A, Barsheshet A, Cannom D, Goldenberg I, McNitt S, Daubert JP, Zareba W, Moss AJ. Left ventricular lead position and clinical outcome in the multicenter automatic defibrillator implantation trial-cardiac resynchronization therapy (MADIT-CRT) trial. Circulation 2011;123:1159-1166.
12. Tracy CM, Epstein AE, Darbar D, Dimarco JP, Dunbar SB, Estes NA III, Ferguson TB Jr, Hammill SC, Karasik PE, Link MS, Marine JE, Schoenfeld MH, Shanker AJ, Silka MJ, Stevenson LW, Stevenson WG, Varosy PD. 2012 ACCF/AHA/HRS focused update of the 2008 guidelines for device-based therapy of cardiac rhythm abnormalities: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 2012;60: 1297-1313.
13. Brignole M, Auricchio A, Baron-Esquivias G, Bordachar P, Boriani G, Breithardt OA, Cleland J, Deharo JC, Delgado V, Elliott PM, Gorenek B, Israel CW, Leclercq C, Linde C, Mont L, Padeletti L, Sutton R, Vardas PE, Guidelines ESCCfP, Zamorano JL, Achenbach S, Baumgartner H, Bax JJ, Bueno H, Dean V, Deaton C, Erol C, Fagard R, Ferrari R, Hasdai D, Hoes AW, Kirchhof P, Knuuti J, Kolh P, Lancellotti P, Linhart A, Nihoyannopoulos P, Piepoli MF, Ponikowski P, Sirnes PA, Tamargo JL, Tendera M, Torbicki A, Wijns W, Windecker S, Document R, Kirchhof P, Blomstrom-Lundqvist C, Badano LP, Aliyev F, Bansch D, Baumgartner H, Bsata W, Buser P, Charron P, Daubert JC, Dobreanu D, Faerestrand S, Hasdai D, Hoes AW, Le Heuzey JY, Mavrakis H, McDonagh T, Merino JL, Nawar MM, Nielsen JC, Pieske B, Poposka L, Ruschitzka F, Tendera M, Van Gelder IC, Wilson CM. 2013 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy: the Task Force on cardiac pacing and resynchronization therapy of the European Society of Cardiology (ESC). Developed in collaboration with the European Heart Rhythm Association (EHRA). Eur Heart J 2013;34:2281-2329.
14. Morani G, Gasparini M, Zanon F, Casali E, Spotti A, Reggiani A, Bertaglia E, Solimene F, Molon G, Accogli M, Tommasi C, Paoletti Perini A, Ciardiello C, Padeletti L. Cardiac resynchronization therapy-defibrillator improves long-term survival compared with cardiac resynchronization therapy-pacemaker in patients with a class IA indication for cardiac resynchronization therapy: data from the Con-tak Italian Registry. Europace 2013;15:1273-1279.
15. Looi KL, Gajendragadkar PR, Khan FZ, Elsik M, Begley DA, Fynn SP, Grace AA, Heck PM, Virdee M, Agarwal S. Cardiac resynchronisation therapy: pacemaker versus internal cardioverter-defibrillator in patients with impaired left ventricular function. Heart 2014;100:794-799.
16. Curtis AB, Yancy CW, Albert NM, Stough WG, Gheorghiade M, Heywood JT, McBride ML, Mehra MR, Oconnor CM, Reynolds D, Walsh MN, Fonarow GC. Cardiac resynchronization therapy utilization for heart failure: findings from IMPROVE HF. Am Heart J 2009;158:956-964.
17. Swedberg K, Cleland J, Cowie MR, Nieminen M, Priori SG, Tavazzi L, van Veldhuisen DJ, Alonso-Pulpon L, Camm J, Dickstein K, Drexler H, Filippatos G, Linde C, Lopez-Sendon J, Santini M, Zannad F. Successful treatment of heart failure with devices requires collaboration. Eur J Heart Fail 2008;10:1229-1235.
18. Boriani G, Mantovani LG, Biffi M, Schalij MJ, Martignani C, Leclercq C, Bax JJ, Auricchio A. Cardiac resynchronization therapy: a cost or an investment? Europace 2011;13(Suppl 2):ii32-ii38.
19. Kutyifa V, Geller L, Bogyi P, Zima E, Aktas MK, Ozcan EE, Becker D, Nagy VK, Kosztin A, Szilagyi S, Merkely B. Effect of cardiac resynchronization therapy with implantable cardioverter defibrillator versus cardiac resynchronization therapy with pacemaker on mortality in heart failure patients: results of a high-volume, single-centre experience. Eur J Heart Fail 2014;16:1323-1330.
20. Cleland JG, Keshavarzi F, Pellicori P, Dicken B. Case selection for cardiac resyn-chronization in atrial fibrillation. Heart Fail Clinics 2013;9:461-474.
21. von Elm E, Altman DG, Egger M, Pocock SJ, Gotzsche PC, Vandenbroucke JP. Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. BMJ 2007;335:806-808.
22. Fine JP, Gray RJ. A proportional hazards model for the subdistribution of a competing risk. J Am Stat Assoc 1999;94:496-509.
23. Bogale N, Priori S, Gitt A, Alings M, Linde C, Dickstein K, Scientific Committee, National Coordinators, and Investigators. The European cardiac resynchronization therapy survey: patient selection and implantation practice vary according to centre volume. Europace 2011;13:1445-1453.
24. Yao G, Freemantle N, Calvert MJ, Bryan S, Daubert JC, Cleland JG. The long-term cost-effectiveness of cardiac resynchronization therapy with or without an implan-table cardioverter-defibrillator. Eur Heart J 2007;28:42-51.
25. Schuchert A, Muto C, Maounis T, Frank R, Boulogne E, Polauck A, Padeletti L, MASCOT study group. Lead complications, device infections, and clinical outcomes in the first year after implantation of cardiac resynchronization therapy-defibrillator and cardiac resynchronization therapy-pacemaker. Europace 2013;15: 71-76.
26. Dickstein K, Normand C, Anker SD, Auricchio A, Lundqvist CB, Bogale N, Cleland J, Filippatos G, Gasparini M, Gitt A, Hindricks G, Kuck KH, Ponikowski P, Stellbrink C, Ruschitzka F, Linde C. European Cardiac Resynchroni-zation Therapy Survey II: rationale and design. Europace 2015;17:137-141.
27. Bai R, Di Biase L, Elayi C, Ching CK, Barrett C, Philipps K, Lim P, Patel D, Callahan T, Martin DO, Arruda M, Schweikert RA, Saliba WI, Wilkoff B, Natale A. Mortality of heart failure patients after cardiac resynchronization therapy: identification of predictors. J Cardiovasc Electrophysiol 2008;19:1259-1265.
28. Lam SK, Tse HF, Lau CP. CRT begets CRT-D: is one better than the other? J Cardiovasc Electrophysiol 2008;19:1266-1269.
29. Lam SK, Owen A. Combined resynchronisation and implantable defibrillator therapy in left ventricular dysfunction: Bayesian network meta-analysis of randomised controlled trials. BMJ 2007;335:925.
30. Cleland JG, Daubert JC, Erdmann E, Freemantle N, Gras D, Kappenberger L, Tavazzi L. Longer-term effects of cardiac resynchronization therapy on mortality in heart failure [the CArdiac REsynchronization-Heart Failure (CARE-HF) trial extension phase]. Eur Heart J 2006;27:1928-1932.
31. Uretsky BF, Thygesen K, Daubert JC, Erdmann E, Freemantle N, Gras D, Kappenberger L, Tavazzi L, Cleland JG. Predictors of mortality from pump failure and sudden cardiac death in patients with systolic heart failure and left ventricular dyssynchrony: results of the CARE-HF trial. J Cardiac Fail 2008;14:670-675.
32. Ruwald MH, Solomon SD, Foster E, Kutyifa V, Ruwald AC, Sherazi S, McNitt S, Jons C, Moss AJ, Zareba W. Left ventricular ejection fraction normalization in cardiac resynchronization therapy and risk of ventricular arrhythmias and clinical outcomes: results from the Multicenter Automatic Defibrillator Implantation Trial with Cardiac Resynchronization Therapy (MADIT-CRT) trial. Circulation 2014; 130:2278-2286.
33. Sebag FA, Lellouche N, Chen Z, Tritar A, O'Neill MD, Gill J, Wright M, Leclercq C, Rinaldi CA. Positive response to cardiac resynchronization therapy reduces arrhythmic events after elective generator change in patients with primary prevention CRT-D. J Cardiovasc Electrophysiol 2014;25:1368-1375.
34. Zecchin M, Proclemer A, Magnani S, Vitali-Serdoz L, Facchin D, Muser D, Nordio A, Barbati G, Puggia I, Sinagra G, Proclemer A. Long-term outcome of'super-responder' patients to cardiac resynchronization therapy. Europace 2014;16:363-371.
35. Castellant P, Fatemi M, Orhan E, Etienne Y, Blanc JJ. Patients with non-ischaemic dilated cardiomyopathy and hyper-responders to cardiac resynchronization therapy: characteristics and long-term evolution. Europace 2009;11:350-355.
36. Gasparini M, Muto C, Iacopino S, Zanon F, Dicandia C, Distefano G, Favale S, Per-aldo Neja C, Bragato R, Davinelli M, Mangoni L, Denaro A. Low-dose dobutamine test associated with interventricular dyssynchrony: a useful tool to identify cardiac resynchronization therapy responders: data from the LOw dose DObutamine stress-echo test in Cardiac Resynchronization Therapy (LODO-CRT) phase 2 study. Am Heart J 2012;163:422-429.
37. Yanagisawa S, Inden Y, Shimano M, Yoshida N, Fujita M, Ohguchi S, Ishikawa S, Kato H, Okumura S, Miyoshi A, Nagao T, Yamamoto T, Hirai M, Murohara T. Clinical characteristics and predictors of super-response to cardiac resynchronization therapy: a combination of predictive factors. PACE 2014;37:1553-1564.
38. Guerra JM, Wu J, Miller JM, Groh WJ. Increase in ventricular tachycardia frequency after biventricular implantable cardioverter defibrillator upgrade. J Cardiovasc Elec-trophysiol 2003;14:1245-1247.
39. Di Cori A, Bongiorni MG, Arena G, Soldati E, Giannola G, Zucchelli G, Balbarini A. New-onset ventricular tachycardia after cardiac resynchronization therapy. J Interv Card Electrophysiol 2005;12:231-235.
40. Boveda S, Marijon E, Jacob S, Defaye P, Winter JB, Bulava A, Gras D, Albenque JP, Combes N, Pavin D, Delarche N, Teubl A, Lambiez M, Chevalier P, Mona Lisa Study Group. Incidence and prognostic significance of sustained ventricular tachycardias in heart failure patients implanted with biventricular pacemakers without a back-up defibrillator: results from the prospective, multicentre, Mona Lisa cohort study. Eur Heart J 2009;30:1237-1244.